StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report released on Saturday. The firm issued a sell rating on the stock.
Separately, HC Wainwright raised their target price on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
Read Our Latest Research Report on SenesTech
SenesTech Stock Up 6.9 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- How to Invest in Biotech Stocks
- Nebius Group: The Rising Star in AI Infrastructure
- What Are Treasury Bonds?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.